Assignee
BIOAXONE BIOSCIENCES INC
US·12 granted patents·5 pending applications·28 citations·filing 2013–2024
Top patents by PatentIndex Score
17 records- 0193US10106525B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·11 cites·3 claims
- 0290US10149856B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Dec 11, 2018·6 cites·6 claims
- 0388US10526313B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Jan 7, 2020·3 cites·2 claims
- 0485US12384759B2Rho kinase inhibitor ba-1049 (r) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2023·Granted Aug 12, 2025·0 cites·18 claims
- 0585US9687483B2Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2016·Granted Jun 27, 2017·7 cites·10 claims
- 0679US10537567B2Kinase inhibitors for treatment of diseaseBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Jan 21, 2020·1 cites·19 claims
- 0778US2024299409A1Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0871US11814361B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2021·Granted Nov 14, 2023·0 cites·14 claims
- 0970US10857157B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2018·Granted Dec 8, 2020·0 cites·14 claims
- 1068US11701366B2Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Jul 18, 2023·0 cites·7 claims
- 1165US11198680B2Rho kinase inhibitor BA-1049 (R) and active metabolites thereofBIOAXONE BIOSCIENCES INC·Filed 2020·Granted Dec 14, 2021·0 cites·2 claims
- 1262US2023399311A1Polymorphs of substituted isoquinoline-based rho kinase inhibitorsBIOAXONE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1361US2022127617A1TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICSBIOAXONE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1457US2022265765A1C3 fusion protein and methods of making and using thereofBIOAXONE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1553US11324802B2C3 fusion protein and methods of making and using thereofBIOAXONE BIOSCIENCES INC·Filed 2018·Granted May 10, 2022·0 cites·9 claims
- 1651US2015297643A1Inhibition of rho and or rock and cell transplantationBIOAXONE BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 1748US11098308B2Treatment of CNS injury with RNAi therapeuticsBIOAXONE BIOSCIENCES INC·Filed 2017·Granted Aug 24, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when BIOAXONE BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →